Shock (Augusta, Ga.) · 2025
Nebulized Epinephrine Improves Oxygenation During Extracorporeal Membrane Oxygenation in Sheep with Smoke Inhalation-Induced Acute Respiratory Distress Syndrome.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Kakizaki Ryuichiro, Nakamoto Kan, Batsaikhan Tsend-Ayush, Enkhbaatar Perenlei
Аннотация
INTRODUCTION: Smoke inhalation injury induces airway edema, obstruction, and bronchospasm, leading to hypoxia and acute respiratory distress syndrome (ARDS). When ARDS is refractory to conventional therapy, veno-venous extracorporeal membrane oxygenation (VV ECMO) is used as a rescue strategy. We hypothesized that nebulized epinephrine improves oxygenation by alleviating airway dysfunction during VV ECMO support.
METHODS: Twelve female Merino sheep were surgically instrumented and subjected to smoke inhalation injury. VV ECMO was initiated when the PaO 2 /FiO 2 ratio dropped below 150 mmHg. The sheep were randomized to receive either saline nebulization (control group, n = 7) or epinephrine nebulization (treatment group, n = 5) every 4 hours. Extracorporeal membrane oxygenation (ECMO) blood flow was maintained at 60-80 mL/kg/min; the sheep remained conscious in cages after ECMO initiation. Cardiopulmonary variables, blood gases, and respiratory mechanics were monitored for 72 hours.
RESULTS: Survival was significantly higher in the treatment group ( P = 0.03). The PaO 2 /FiO 2 ratio improved significantly in the treatment group at 30 and 36 hours compared with the control group ( P < 0.05), with a positive correlation between oxygenation and time (correlation coefficient = 0.8, P < 0.01). The tracheal wet-to-dry weight ratio was lower in the treatment group ( P < 0.05), indicating reduced airway edema. No significant systemic cardiovascular effects were observed.
CONCLUSIONS: This study demonstrates that nebulized epinephrine improved oxygenation, reduced airway edema, and enhanced survival in an ovine model of smoke inhalation-induced ARDS supported with VV ECMO. These findings suggest that epinephrine nebulization may provide a promising adjunctive therapy to improve outcomes and facilitate shorter ECMO duration in smoke inhalation-associated ARDS.
METHODS: Twelve female Merino sheep were surgically instrumented and subjected to smoke inhalation injury. VV ECMO was initiated when the PaO 2 /FiO 2 ratio dropped below 150 mmHg. The sheep were randomized to receive either saline nebulization (control group, n = 7) or epinephrine nebulization (treatment group, n = 5) every 4 hours. Extracorporeal membrane oxygenation (ECMO) blood flow was maintained at 60-80 mL/kg/min; the sheep remained conscious in cages after ECMO initiation. Cardiopulmonary variables, blood gases, and respiratory mechanics were monitored for 72 hours.
RESULTS: Survival was significantly higher in the treatment group ( P = 0.03). The PaO 2 /FiO 2 ratio improved significantly in the treatment group at 30 and 36 hours compared with the control group ( P < 0.05), with a positive correlation between oxygenation and time (correlation coefficient = 0.8, P < 0.01). The tracheal wet-to-dry weight ratio was lower in the treatment group ( P < 0.05), indicating reduced airway edema. No significant systemic cardiovascular effects were observed.
CONCLUSIONS: This study demonstrates that nebulized epinephrine improved oxygenation, reduced airway edema, and enhanced survival in an ovine model of smoke inhalation-induced ARDS supported with VV ECMO. These findings suggest that epinephrine nebulization may provide a promising adjunctive therapy to improve outcomes and facilitate shorter ECMO duration in smoke inhalation-associated ARDS.